• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tvardi Therapeutics, Inc. - Common Stock (NQ:TVRD)

    40.44 +0.26 (+0.65%)
    Streaming Delayed Price Updated: 9:36 AM EDT, Oct 7, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,596
    Open 39.16
    Bid (Size) 39.60 (1)
    Ask (Size) 40.40 (1)
    Prev. Close 40.18
    Today's Range 39.16 - 40.44
    52wk Range 15.13 - 42.10
    Shares Outstanding 1,524,535
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Tvardi Therapeutics to Participate in the Cantor Global Healthcare Conference
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Tvardi Posts Q2 Net Income Turnaround
    Via The Motley Fool
    Topics Intellectual Property

    Performance

    YTD
    +121.6%
    +121.6%
    1 Month
    +36.3%
    +36.3%
    3 Month
    +87.9%
    +87.9%
    6 Month
    +121.6%
    +121.6%
    1 Year
    +121.6%
    +121.6%

    More News

    Read More
    Tvardi Therapeutics Announces Second Quarter 2025 Results and Provides Business Update
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Tvardi Therapeutics to Participate in the BTIG Virtual Biotechnology Conference
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Recently Listed Tvardi Therapeutics' Lead Drug 'Positioned To Drive Broad Improvement', Analyst Sees Over 150% Stock Upside
    Via Benzinga
    This Modine Manufacturing Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
    Via Benzinga
    Tvardi Therapeutics Announces Completion of Enrollment in Phase 2 Clinical Trial of TTI-101 in Idiopathic Pulmonary Fibrosis
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Tvardi Therapeutics to Participate in Upcoming Investor Conferences
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Tvardi Therapeutics Announces First Quarter 2025 Results and Provides Business Update
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    Tvardi Therapeutics Announces Presentation at the American Thoracic Society 2025 Annual Conference
    From Tvardi Therapeutics, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Friday's Pre-Market Session
    Via Benzinga
    Why Coursera Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
    Via Benzinga

    Frequently Asked Questions

    Is Tvardi Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Tvardi Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Tvardi Therapeutics, Inc. - Common Stock trade on?
    Tvardi Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Tvardi Therapeutics, Inc. - Common Stock?
    The ticker symbol for Tvardi Therapeutics, Inc. - Common Stock is TVRD on the Nasdaq Stock Market
    What is the current price of Tvardi Therapeutics, Inc. - Common Stock?
    The current price of Tvardi Therapeutics, Inc. - Common Stock is 40.44
    When was Tvardi Therapeutics, Inc. - Common Stock last traded?
    The last trade of Tvardi Therapeutics, Inc. - Common Stock was at 10/07/25 09:36 AM ET
    What is the market capitalization of Tvardi Therapeutics, Inc. - Common Stock?
    The market capitalization of Tvardi Therapeutics, Inc. - Common Stock is 61.65M
    How many shares of Tvardi Therapeutics, Inc. - Common Stock are outstanding?
    Tvardi Therapeutics, Inc. - Common Stock has 62M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.